The race to create orgasm enhancing drugs to women has just begun.
An interesting article in Plos written by a Leonore Tiefer, a Professor of psychiatry, shed the light on how could be interacting the disease mongering in one hand and the sexual functions issues of women in a another hand. But the pitfall of such a position of suspecting systematically the pharmaceutical industry of being greedy could be to let those dysfunctions in the same uncomfortable situation as orphan diseases which as we know suffer from a lack of response (be they pharmaceutical responses or psychological responses, or technological response).
An article of press in the International Herald Tribune by Abby Ellin, in the July 4 edition takes a more balanced point a few when it reports in response to Dr Tiefer the words of Dr Marcus saying: “to say that women complains about their sex life because the pharmaceutical companies told them to is really insulting to women”
More content and references:
- More Women Seek Over-the-Counter Sexual Remedies (nytimes.com)
- Sexual Dysfunction and Medications: Exploring the Link (everydayhealth.com)
- Pharma reviving Boehringer’s female sexual dysfunction drug gets $17.6M (medcitynews.com)
- Libido Supplements and Vitamins for Sex – Do They Work? (everydayhealth.com)
- Low Testosterone and Your Sex Life (everydayhealth.com)
- GlaxoSmithKline (GSK) Fined $3 Billion for Criminal and Civil Misconduct (investorguide.com)